Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid.
A quantitative kinetic technique using a scintillation camera has been developed for investigating lymph drainage and the uptake in the lymph nodes of 99mTcSb2S3 colloid injected subcutaneously. Twenty-two patients with primary malignant melanoma were examined. Lymph-node dissection was performed and 185 lymph nodes were individually measured for radioactivity. The kinetics of colloid uptake in individual nodes can be expressed by a simple two-compartment model. The outflow of colloid from the injection site was found to be monoexponential, and the tissue volume containing the injected colloid at the injection site increased asymptotically with time. A model has been developed for calculating absorbed doses at the injection site and in organs with colloid uptake. The following absorbed doses were estimated (muGy/MBq): whole body 0.7-4.5, gonads 0-22, liver 1.0-3.9, lymph nodes up to 1000 and injection site about 10,000. Possible biological effects in the skin and effective dose equivalents have been estimated when using other lymphoscintigraphic agents.
D000965:Antimony; D006801:Humans; D007267:Injections; D007700:Kinetics; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D061305:Lymphoscintigraphy; D008433:Mathematics; D008545:Melanoma / Q000000981:diagnostic imaging; D008954:Models, Biological; D011874:Radiometry; D013667:Technetium; D017556:Technetium Compounds; D013997:Time Factors
D017556:Technetium Compounds; C019096:technetium Tc 99m antimony sulfide; D013667:Technetium; D000965:Antimony